Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 10Neutropenia 8Breast Neoplasms 8Leukemia, Myeloid, Acute 7Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Hematologic Neoplasms 4Febrile Neutropenia 4Leukemia, Monocytic, Acute 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Osteosarcoma 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Teratoma 1Solid Tumors 1Sarcoma, Myeloid 1Sarcoma, Clear Cell 1Rhabdoid Tumor 1Retinoblastoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1

Interventions

Cisplatin 10Ifosfamide 9Etoposide 9Paclitaxel 8Filgrastim 8Carboplatin 7Bleomycin 7Peripheral Blood Stem Cell Transplantation 4pegfilgrastim 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3liposomal amphotericin B 2Thiotepa 2Therapeutics 2Specimen Handling 2Mesna 2Cyclophosphamide 2Brentuximab Vedotin 2sargramostim 1pegylated granulocyte colony-stimulating factor 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Vinblastine 1Taxes 1Sunitinib 1Standard of Care 1Second-Look Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Embryonal × pegylated granulocyte colony-stimulating factor × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡